News

LNC Therapeutics announces the grant of the first worldwide patent relating to the therapeutic...

Mar 26, 2019

Dr. Mathieu Simon and Catherine Combot-Plétan join the Board of Directors of biotech firm LNC...

Dec 11, 2018

LNC Therapeutics acquires exclusive license for the Christensenella patent from Cornell University

Oct 15, 2018

LNC Therapeutics launches a new clinical trial, OBEMINALE 2, and treats its first patient

Oct 2, 2018

Christensenella: the cornerstone of the gut microbiota?

Jul 6, 2018

LNC Therapeutics appoints new CEO, Dr. Georges Rawadi, and accelerates development in microbiome...

Apr 17, 2018